logo-loader

Aeolus Pharmaceuticals, Inc.

Receive alerts
Market:
OTCMKTS
Market Cap:
$228.13 k
Price
0.00 USD
Change
36.36%
52 weeks high
0.00
52 weeks low
0.00

In brief

Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. Its compound, AEOL 10150, is entering human clinical trials in oncology. AEOL 10150 had been tested in two Phase-I clinical trials.